CARLSBAD, Calif., Sept. 16, 2008 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company involved in the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, today announced it will present at the UBS Global Life Sciences Conference on Monday, September 22, 2008 at 1:30 p.m. Eastern Time at the Grand Hyatt New York in New York City.
Dirk Kuyper, President and Chief Executive Officer, will provide a corporate overview of the Company. A live audio webcast of the presentation will be accessible through Alphatec Spine's investor relations web site at www.alphatecspine.com. An archived edition of the presentation will be available later that day and archived for at least 30 days.
About Alphatec Spine
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec Holdings, Inc. (Nasdaq:ATEC) Alphatec Spine is a medical device company involved in the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, with a focus on treating disorders related to the aging spine. The company's mission is to combine world-class customer service with innovative, surgeon-driven design that will help improve the aging patient's quality of life. The company is poised to achieve its goal through new solutions for patients with osteoporosis and other aging spine deformities, improved minimally invasive products and techniques, and integrated biologics solutions. In addition to its U.S. operations, Alphatec Spine also markets its spine products in Europe. In Asia, the company markets a broad line of spine and orthopedic products through its subsidiary, Alphatec Pacific, Inc. For more information, please visit http://www.alphatecspine.com.
The Alphatec Holdings, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3520